Sai Life Sciences Ltd

Sai Life Sciences Limited — Closure of Trading Window from 01 October 2026 till the end of 48 hours after the announcement of the unaudited financial results for the second quarter and half year ending 30 September 2026.

Filing Status

• Board approved allotment of 24,000 equity shares under ESOP 2008 on 18 Sep 2026.
• Capital increased from ₹21,23,94,217 to ₹21,24,18,216 post allotment.

AGM Details

• Date and time: 17 September 2026, 10:30 AM IST.
• Mode: VC/OAVM.
• Record date: 10 September 2026.
• Total shareholders on record: 142,998.
• Meeting duration: 10:30–11:25 AM.

Key Resolutions

• Ordinary: Adoption of standalone and consolidated financial statements and reports.
• Ordinary: Re-appointment of director retiring by rotation.

Voting Results

• Financial statements resolution passed with overwhelming support.
• Director re-appointment resolution passed with high in-favour votes.

Director Changes

• Director retiring by rotation re-appointed.

AGM details

• Date/time/mode: 17 September 2026, 10:30 IST; VC/OAVM.
• Attendance: 94 members representing 7,76,98,047 shares.

Ordinary business

• Adopt standalone and consolidated financial statements for year ended 31 March 2026.
• Re-appointment of director retiring by rotation.

Voting status

• E-voting results to be declared; to be disclosed to exchanges and on company site.

Director changes

• Director retirement by rotation; re-appointment proposed.

Share Capital Change

• Allotment of 14,600 ESOP 2008 and 66,000 MESOP 2018 shares on exercise.
• Issued share capital increased from ₹21,23,13,617 to ₹21,23,94,216.
• Date of issue of shares: 01-09-2026.
• Number of shares issued: 80,600.
• Par value per share: ₹1; ISIN INE570L01029.
• Exercise prices: ₹188.90 for ESOP 2008; ₹23.30 for MESOP 2018.
• Premium per share: ₹187.90 (ESOP 2008); ₹22.30 (MESOP 2018).
• Total issued shares after issue: 21,23,94,216.
• Allotted shares identical to existing shares.
• Lock-in on shares: Not Applicable.

AGM and IAR access

• Regulation 36(1)(b) web-link letters sent to Members without registered email for IAR access.
• Web-link and exact navigation path provided to access Integrated Annual Report for FY 2025-26.
• 27th AGM scheduled for September 17, 2026 at 10:30 AM IST via VC/OAVM.
• Cut-off date for unregistered emails: August 14, 2026.
• Members urged to update email addresses with DP/RTA to receive future communications electronically.

Overview

• Main business: Contract Research, Development and Manufacturing (CRDMO) services.
• Reporting boundary: Standalone BRSR for FY2025-26.
• Exports contribute 96.84% of turnover across 16 countries.

Key ESG Risks & Opportunities

• Climate risks (physical/transition) mitigated via ERM and science-based targets.
• Energy costs mitigated by ISO 50001, audits and renewables.
• Water stress managed via ZLD and recycling initiatives.
• Waste management emphasizes recycling and 99.9% landfill diversion.
• OHS safety programs; LTIFR 0 for employees and workers.
• Labor rights policies and supplier codes; strong due diligence.
• Ethics/ABAC policy; whistleblower mechanism; no bribery incidents.
• 100% critical suppliers assessed for ESG; 172 suppliers evaluated for environmental impacts.
• Product safety: no product recalls in FY2025-26.

Governance & Policy Highlights

• CSR & Sustainability Committee oversees ESG strategy and policy implementation.
• Board conducts quarterly reviews of statutory compliance.
• Policies include ABAC, anti-bribery, whistleblower, supplier code, and human rights.
• ISO 14001/45001: 100% Indian sites target by 2026-27.
• External assurance by TÜV India; ISAE 3000 and AA1000AS scope.
• No material penalties disclosed; governance and ethics frameworks in place.

Social Responsibility & Workforce

• Total employees: 3,909; permanent 3,806; male 3,238; female 568.
• Total workers: 1,315; male 1,235; female 80.
• Board women: 17%; KMP women: 17%.
• Wellbeing spend: 1.21% of revenue.
• POSH complaints: 1 in FY2025-26; 2 in FY2024-25.
• CSR beneficiaries include LVPEI centres; 19,054 people benefited.

Environmental Performance

• Total energy: 385,999 GJ; renewables 46%.
• GHG: Scope1 22,445; Scope2 MB 8,630; Scope3 90,272 tCO2e.
• Water withdrawal 183,968 KL; consumption 147,614 KL.
• Waste: total 15,256.5 MT; hazardous 12,122 MT; landfill 659.63 MT; incineration 56.4 MT.
• Waste recovered: 14,420.06 MT; landfill diversion ~95.6%.
• ZLD at Bidar; EPR for plastics; solvent recovery ~295 KL/year.

Stakeholder Engagement & Complaints

• Key stakeholder groups: investors, customers, suppliers, government bodies, communities.
• Engagement channels: investor calls, AGMs, customer meetings, supplier audits, community meetings; quarterly/annual cadence.
• Customer complaints: 12 filed in FY2025-26; 11 pending.
• POSH complaints: FY2025-26: 1; FY2024-25: 2.
• Grievance mechanisms: complaint boxes, whistleblower policy; CSR community programs.

Other Notable Metrics

• MSME sourcing: 34% of inputs.
• Local sourcing: 78% of inputs sourced from district/nearby districts.
• New suppliers screened for social and environmental criteria; supplier Code of Conduct.
• Public policy: no political contributions in FY2025-26.
• Independent assurance: TÜV India for non-financial disclosures; BRSR Core KPIs reasonably assured.

Key highlights FY2025-26

• Revenue from operations: ₹2,192 Cr.
• EBITDA: ₹661 Cr.
• EBITDA margin: 30.1%.
• PAT: ₹349 Cr.
• PAT margin: 15.9%.
• ROE: 14.61%.
• Capex FY2025-26: ₹633 Cr.
• Planned capex FY2026-27: ₹1,100–₹1,300 Cr.
• Net debt to equity: 0.01x.
• Dividends not declared for FY2025-26.

AGM Details

• Date/time/mode: Sept 17, 2026, 10:30 IST; via VC/OAVM.
• Cut-off for e-voting: Sept 10, 2026.
• Remote e-voting window: Sept 14–16, 2026.
• Venue deemed at registered office; meeting via VC/OAVM.

Key Resolutions

• Adopt standalone and consolidated financial statements for year ended 31 Mar 2026.
• Re-appointment of Krishnam Raju Kanumuri as Director (retiring by rotation).

Voting and Results

• Voting results not disclosed in filing.

Director remuneration

• Remuneration FY2025-26: INR 130,765,004.
• Role: MD & CEO; Executive Director under promoter category.
• Terms remain same; remuneration unchanged.